We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants

Delisted

NKGNW was delisted on the 4th of March, 2025.

31 hedge funds and large institutions have $198K invested in NKGen Biotech, Inc. Warrants in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

48% more funds holding

Funds holding: 2131 (+10)

77% less capital invested

Capital invested by funds: $875K → $198K (-$676K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
31
Holders Change
+10
Holders Change %
+47.62%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
Reduced
5
Closed
2
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$10K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$52.2K
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$14.7K -$13 -100 -0.1%
SCM
3
Shaolin Capital Management
Florida
$13.2K -$270 -2,000 -1%
ETH
4
Exos TFP Holdings
New York
$11.8K
AA
5
AQR Arbitrage
Connecticut
$9.93K -$708 -5,250 -4%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$9.89K
Jane Street
7
Jane Street
New York
$8.09K
PC
8
Periscope Capital
Ontario, Canada
$7.46K -$3.71K -27,490 -23%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
9
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$7.07K +$13.5K +100,000 New
KL
10
KIM LLC
Kansas
$6.51K +$12.4K +92,040 New
PSAMP
11
P. Schoenfeld Asset Management (PSAM)
New York
$6.46K
TCA
12
Taconic Capital Advisors
New York
$4.95K
PAMP
13
Polar Asset Management Partners
Ontario, Canada
$4.85K +$8.09K +60,000 New
WAM
14
Wolverine Asset Management
Illinois
$4.24K +$7.08K +52,466 New
Walleye Capital
15
Walleye Capital
New York
$4.22K +$7.05K +52,290 New
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$3.54K
AIMCA
17
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.23K
MTCM
18
Mint Tower Capital Management
Netherlands
$3K
FBCM
19
Fort Baker Capital Management
California
$2.98K +$4.98K +36,934 New
JFG
20
Jefferies Financial Group
New York
$2.83K
SCM
21
Saba Capital Management
New York
$2.52K
ACM
22
Atalaya Capital Management
New York
$2.4K
Walleye Trading
23
Walleye Trading
New York
$2.09K +$3.48K +25,830 New
SSA
24
Schonfeld Strategic Advisors
New York
$2.02K +$3.37K +25,000 New
JP Morgan Chase
25
JP Morgan Chase
New York
$1.49K

NKGNW Hedge Fund Activity: Q4 2023 in Review

31 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2023, worth a combined $198K — down 77% from $875K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NKGNW positions and 2 closed out — a net gain of 10 holders — while 0 added to existing stakes and 5 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $13.5K. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $59.2K sold.

  • 31 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2023, up from 21 in Q3 2023.
  • Funds reported $198K of NKGen Biotech, Inc. Warrants stock for Q4 2023, down 77% quarter-over-quarter.
  • 12 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2023 and 2 closed out, a net change of +10 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q4 2023 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $13.5K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q4 2023 was BNP Paribas Financial Markets, an estimated $59.2K sold.

Based on aggregated 13F filings for Q4 2023.